Cleared Traditional

K971113 - DMA TRIGLYCERIDES PROCEDURES

K971113 is the FDA 510(k) clearance for DMA TRIGLYCERIDES PROCEDURES by Data Medical Associates, Inc.. It is a Class 1 Chemistry device (product code CDT) cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K971113 · Data Medical Associates, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1997
Decision
63d
Days
Class 1
Risk

K971113 is an FDA 510(k) clearance for the DMA TRIGLYCERIDES PROCEDURES. Classified as Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides (product code CDT), Class I - General Controls.

Submitted by Data Medical Associates, Inc. (Arlington, US). The FDA issued a Cleared decision on May 29, 1997 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1705 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Data Medical Associates, Inc. devices

Submission Details

510(k) Number K971113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 1997
Decision Date May 29, 1997
Days to Decision 63 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 88d · This submission: 63d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1705
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CDT Lipase Hydrolysis/glycerol Kinase Enzyme, Triglycerides

All 112
Devices cleared under the same product code (CDT) and FDA review panel - the closest regulatory comparables to K971113.
VITALAB TRIGLYCERIDES REAGENT AND VITALAB CALIBRATOR
K034000 · Clinical Data, Inc. · Mar 2004
TGL FLEX REAGENT CARTRIDGE
K010871 · Dade Behring, Inc. · Jul 2001
WAKO L-TYPE TRIGLYCERIDE TEST
K993466 · Wako Chemicals USA, Inc. · Nov 1999
OLYMPUS LIPASE REAGENT
K963424 · Olympus America, Inc. · Jan 1997
TRIGLYCERIDE-SL ASSAY CATALOGUE NO. 236-60
K961281 · Diagnostic Chemicals , Ltd. · Aug 1996
TRUE TRIGLYCERIDE
K960088 · Diagnostic Chemicals , Ltd. · Apr 1996